인쇄하기
취소
|
A tetravalent cell-cultured influenza vaccine which can be administered in the entire age group over 3 will be launched in Korea for the first time in the world.
On the 23rd, SK Chemicals(CEO Man-hoon Park) announced the launch of the tetravalent cell-cultured influenza vaccine ‘Sky Cellflu Quadrivalent’ and the beginning of active vaccination in hospitals and clinics across the nation
Sky Ce...